CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease

BACKGROUND AND OBJECTIVES: CSF tau phosphorylated at threonine 181 (p-tau181) is a widely used biomarker for Alzheimer disease (AD) and has recently been regarded to reflect β-amyloid and/or p-tau deposition in the AD brain. Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurihara, Masanori, Komatsu, Hiroki, Sengoku, Renpei, Shibukawa, Mari, Morimoto, Satoru, Matsubara, Tomoyasu, Arakawa, Akira, Orita, Makoto, Ishibashi, Kenji, Mitsutake, Akihiko, Shibata, Shota, Ishiura, Hiroyuki, Adachi, Kaori, Ohse, Kensuke, Hatano, Keiko, Ihara, Ryoko, Higashihara, Mana, Nishina, Yasushi, Tokumaru, Aya Midori, Ishii, Kenji, Saito, Yuko, Murayama, Shigeo, Kanemaru, Kazutomi, Iwata, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990848/
https://www.ncbi.nlm.nih.gov/pubmed/36517236
http://dx.doi.org/10.1212/WNL.0000000000201647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990848/
https://www.ncbi.nlm.nih.gov/pubmed/36517236
http://dx.doi.org/10.1212/WNL.0000000000201647

Ejemplares similares